CWA Asset Management Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,011
Closed -$251K 183
2017
Q2
$251K Buy
2,011
+35
+2% +$4.15K 0.08% 138
2017
Q1
$234K Buy
+1,976
New +$224K 0.08% 134
2016
Q4
Sell
-1,976
Closed -$249K 163
2016
Q3
$249K Hold
1,976
0.14% 115
2016
Q2
$231K Buy
+1,976
New +$224K 0.14% 123
2016
Q1
Sell
-2,048
Closed -$204K 138
2015
Q4
$204K Buy
+2,048
New +$200K 0.23% 127

Other funds holding ZBH

CWA Asset Management Group's ZBH Position: Q3 2017 in Review

CWA Asset Management Group sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 2,011 shares — an estimated $251K sold.

CWA Asset Management Group first reported a position in ZBH in Q4 2015 and held it in 5 quarters. The position peaked at $251K in Q2 2017. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

  • CWA Asset Management Group reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
  • CWA Asset Management Group sold 2,011 Zimmer Biomet shares in Q3 2017, an estimated $251K.
  • CWA Asset Management Group first reported a position in Zimmer Biomet in Q4 2015 and held it in 5 quarters.
  • CWA Asset Management Group's Zimmer Biomet position peaked at $251K in Q2 2017.
  • 818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on CWA Asset Management Group's 13F filing for Q3 2017, filed 13 Nov 2017.